{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:40:39Z","timestamp":1794746439828,"version":"4.9.1"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>The diagnosis of low-grade adrenal cortical carcinoma (ACC) confined to the adrenal gland can be challenging. Although there are diagnostic and prognostic molecular tests for ACC, they remain largely unutilized. We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, \u03b3-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate\u2013based tumor grade. IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, \u03b3-H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas. Not all biomarkers were informative in all carcinomas. IGF-2 was the most useful biomarker of malignancy irrespective of tumor grade and cytomorphologic features, as juxtanuclear Golgi-pattern IGF-2 reactivity optimized for high specificity was identified in up to 80% of carcinomas and in no adenomas. Loss rather than qualitative alterations of the reticulin framework yielded statistical difference between carcinoma and adenoma. Angioinvasion defined as tumor cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the best prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade ACCs. Low mitotic tumor grade, Weiss score, global loss of DAXX expression, and high phospho-mTOR expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease. Our results underscore the importance of careful morphologic assessment coupled with ancillary diagnostic and prognostic biomarkers of ACC.<\/jats:p>","DOI":"10.1097\/pas.0000000000000943","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T12:47:04Z","timestamp":1504702024000},"page":"201-213","source":"Crossref","is-referenced-by-count":82,"title":["Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Ozgur","family":"Mete","sequence":"first","affiliation":[{"name":"Department of Pathology, University Health Network"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Endocrine Oncology Site Group, The Princess Margaret Cancer Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Gucer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Recep Tayyip Erdogan University, Rize"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kefeli","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ondokuz Mayis University, Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Health Network"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Endocrine Oncology Site Group, The Princess Margaret Cancer Centre, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240215","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"R2-20240215","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R3-20240215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","article-title":"Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival","volume":"27","author":"de Reyni\u00e8s","year":"2009","journal-title":"J Clin Oncol"},{"key":"R4-20240215","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"suppl 1","key":"R5-20240215","first-page":"98","article-title":"Dissecting morphological and molecular heterogeneity in adrenocortical carcinoma","volume":"31","author":"Duregon","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"R7-20240215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R8-20240215","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R9-20240215","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"key":"R10-20240215","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","article-title":"The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases","volume":"37","author":"Duregon","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R11-20240215","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum Pathol"},{"key":"R12-20240215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"key":"R13-20240215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss score and beyond-histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer"},{"key":"R14-20240215","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0b013e3181e2b726","article-title":"Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior","volume":"34","author":"Papotti","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R15-20240215","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.5858\/2010-0320-RA.1","article-title":"Adrenocortical tumors: an integrated clinical, pathologic, and molecular approach at the University of Michigan","volume":"134","author":"Giordano","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R16-20240215","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/PAS.0b013e31825a6308","article-title":"Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE","volume":"36","author":"Tissier","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R17-20240215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAT.0b013e32835f45c5","article-title":"Precursor lesions of endocrine system neoplasms","volume":"45","author":"Mete","year":"2013","journal-title":"Pathology"},{"key":"R18-20240215","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","article-title":"Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and \u03b2-catenin","volume":"181","author":"Heaton","year":"2012","journal-title":"Am J Pathol"},{"key":"R19-20240215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2011.09.044","article-title":"Gene expression profiling in adrenocortical neoplasia","volume":"351","author":"Assie","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R20-20240215","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"R21-20240215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ecl.2015.02.004","article-title":"The genetics of adrenocortical tumors","volume":"44","author":"Espiard","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R22-20240215","first-page":"852","article-title":"Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas","volume":"77","author":"Ilvesm\u00e4ki","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20240215","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.2011.119","article-title":"Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation","volume":"24","author":"Mete","year":"2011","journal-title":"Mod Pathol"},{"key":"R24-20240215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/PAS.0b013e31820bcf21","article-title":"The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma","volume":"35","author":"Giordano","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R25-20240215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12022-012-9225-8","article-title":"Prognostic and predictive markers in medullary thyroid carcinoma","volume":"23","author":"Erovic","year":"2012","journal-title":"Endocr Pathol"},{"key":"R26-20240215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-012-9222-y","article-title":"Biomarkers of parathyroid carcinoma","volume":"23","author":"Erovic","year":"2012","journal-title":"Endocr Pathol"},{"key":"R27-20240215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hed.22908","article-title":"Parathyroid cancer: outcome analysis of 16 patients treated at the Princess Margaret Hospital","volume":"35","author":"Erovic","year":"2013","journal-title":"Head Neck"},{"key":"R28-20240215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12022-016-9424-9","article-title":"The impact of phosphohistone-H3-assisted mitotic count and Ki67 score in the determination of tumor grade and prediction of distant metastasis in well-differentiated pancreatic neuroendocrine tumors","volume":"27","author":"Ozturk Sari","year":"2016","journal-title":"Endocr Pathol"},{"key":"R29-20240215","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1073\/pnas.84.6.1590","article-title":"Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues","volume":"84","author":"Voutilainen","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-20240215","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1210\/endo.131.6.1446644","article-title":"Insulin-like growth factor-II (IGF-II) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine\/paracrine role for IGF-II","volume":"131","author":"Han","year":"1992","journal-title":"Endocrinology"},{"key":"R31-20240215","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1530\/ERC-15-0086","article-title":"Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors","volume":"22","author":"Nielsen","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"R32-20240215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.ejhg.5200649","article-title":"Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome","volume":"9","author":"Gaston","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"R33-20240215","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1245\/s10434-014-3768-5","article-title":"Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma","volume":"21","author":"Patel","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R34-20240215","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1038\/onc.2017.54","article-title":"P53\/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model","volume":"36","author":"Batisse-Lignier","year":"2017","journal-title":"Oncogene"},{"key":"R35-20240215","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1385\/EP:12:4:429","article-title":"Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms","volume":"12","author":"Erickson","year":"2001","journal-title":"Endocr Pathol"},{"key":"R36-20240215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2559.2006.02505.x","article-title":"IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours","volume":"49","author":"Schmitt","year":"2006","journal-title":"Histopathology"},{"key":"R37-20240215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/his.12283","article-title":"Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers","volume":"64","author":"Wang","year":"2014","journal-title":"Histopathology"},{"key":"R38-20240215","first-page":"1713","article-title":"Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors","volume":"83","author":"Boulle","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-20240215","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1210\/endo.141.9.7632","article-title":"Fibroblast growth factor-2 inhibits the maturation of pro-insulin-like growth factor-II(Pro-IGF-II) and the expression of insulin-like growth factor binding protein-2 (IGFBP-2) in the human adrenocortical tumor cell line NCI-H295R","volume":"141","author":"Boulle","year":"2000","journal-title":"Endocrinology"},{"key":"R40-20240215","doi-asserted-by":"crossref","first-page":"18443","DOI":"10.1074\/jbc.273.29.18443","article-title":"Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis","volume":"273","author":"Duguay","year":"1998","journal-title":"J Biol Chem"},{"key":"R41-20240215","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/07435800009048609","article-title":"p53 and Ki67 in adrenocortical tumors","volume":"26","author":"Arola","year":"2000","journal-title":"Endocr Res"},{"key":"R42-20240215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","article-title":"Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas","volume":"55","author":"Morimoto","year":"2008","journal-title":"Endocr J"},{"key":"R43-20240215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<146::AID-PATH744>3.0.CO;2-7","article-title":"Expression of p53 in adrenocortical tumours: clinicopathological correlations","volume":"181","author":"McNicol","year":"1997","journal-title":"J Pathol"},{"key":"R44-20240215","first-page":"790","article-title":"p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies","volume":"78","author":"Reincke","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-20240215","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MP.0000081730.72305.81","article-title":"Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis","volume":"16","author":"Stojadinovic","year":"2003","journal-title":"Mod Pathol"},{"key":"R46-20240215","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jpedsurg.2016.07.014","article-title":"Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: is there a correlation?","volume":"51","author":"Das","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R47-20240215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.010","article-title":"Towards an understanding of the role of p53 in adrenocortical carcinogenesis","volume":"351","author":"Wasserman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R48-20240215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ijc.2910540310","article-title":"p53 mutations in sporadic adrenocortical tumors","volume":"54","author":"Ohgaki","year":"1993","journal-title":"Int J Cancer"},{"key":"R49-20240215","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: clinical, morphologic, and molecular characterization","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2B","key":"R50-20240215","first-page":"1303","article-title":"Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas","volume":"17","author":"Edgren","year":"1997","journal-title":"Anticancer Res"},{"key":"R51-20240215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-11-0806","article-title":"Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients","volume":"166","author":"Fragoso","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R52-20240215","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/cc.7.12.6180","article-title":"Kinetochore-microtubule interactions \u201cin check\u201d by Bub1, Bub3 and BubR1: the dual task of attaching and signalling","volume":"7","author":"Logarinho","year":"2008","journal-title":"Cell Cycle"},{"key":"R53-20240215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hed.21532","article-title":"BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival","volume":"33","author":"Rizzardi","year":"2011","journal-title":"Head Neck"},{"key":"R54-20240215","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1349-7006.2009.01457.x","article-title":"High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer","volume":"101","author":"Ando","year":"2010","journal-title":"Cancer Sci"},{"key":"R55-20240215","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.bjc.6605161","article-title":"BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers","volume":"101","author":"Lee","year":"2009","journal-title":"Br J Cancer"},{"key":"R56-20240215","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/modpathol.2012.242","article-title":"Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor\/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation","volume":"26","author":"Stricker","year":"2013","journal-title":"Mod Pathol"},{"key":"R57-20240215","first-page":"389","article-title":"Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas","volume":"30","author":"Pinto","year":"2008","journal-title":"Cell Oncol"},{"key":"R58-20240215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cancergencyto.2006.11.012","article-title":"Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer","volume":"174","author":"Yamamoto","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"R59-20240215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2013.12.022","article-title":"Microtubule-dependent regulation of mitotic protein degradation","volume":"53","author":"Song","year":"2014","journal-title":"Mol Cell"},{"key":"R60-20240215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm3760","article-title":"Mitosis: microtubules protect spindle assembly factors","volume":"15","author":"Wrighton","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R61-20240215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.2471","article-title":"Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas","volume":"217","author":"Barbagallo","year":"2009","journal-title":"J Pathol"},{"key":"R62-20240215","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1038\/sj.onc.1205711","article-title":"The Nek2 protein kinase: a novel regulator of centrosome structure","volume":"21","author":"Fry","year":"2002","journal-title":"Oncogene"},{"key":"R63-20240215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1667\/RR3211","article-title":"Inhibition of centrosome separation after DNA damage: a role for Nek2","volume":"162","author":"Fletcher","year":"2004","journal-title":"Radiat Res"},{"key":"R64-20240215","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1087057110376537","article-title":"Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase","volume":"15","author":"Hayward","year":"2010","journal-title":"J Biomol Screen"},{"key":"R65-20240215","first-page":"305","article-title":"Gamma-H2AX\u2014a novel biomarker for DNA double-strand breaks","volume":"22","author":"Kuo","year":"2008","journal-title":"In Vivo"},{"key":"R66-20240215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1139\/o03-042","article-title":"Characteristics of gamma-H2AX foci at DNA double-strand breaks sites","volume":"81","author":"Pilch","year":"2003","journal-title":"Biochem Cell Biol"},{"key":"R67-20240215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156800906776842957","article-title":"gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy","volume":"6","author":"Kao","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"R68-20240215","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1074\/jbc.M310030200","article-title":"Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy","volume":"279","author":"Taneja","year":"2004","journal-title":"J Biol Chem"},{"key":"R69-20240215","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/sj.onc.1210142","article-title":"PBK\/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response","volume":"26","author":"Ayll\u00f3n","year":"2007","journal-title":"Oncogene"},{"key":"R70-20240215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.humpath.2009.05.016","article-title":"PBK\/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma","volume":"41","author":"He","year":"2010","journal-title":"Hum Pathol"},{"key":"R71-20240215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2007.04.048","article-title":"Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells","volume":"133","author":"Zhu","year":"2007","journal-title":"Gastroenterology"},{"key":"R72-20240215","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1158\/0008-5472.CAN-06-1601","article-title":"PDZ-binding kinase\/T-LAK cell-originated protein kinase, a putative cancer\/testis antigen with an oncogenic activity in breast cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"R73-20240215","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/bjc.2016.394","article-title":"Overexpression of PBK\/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma","volume":"116","author":"Ohashi","year":"2017","journal-title":"Br J Cancer"},{"key":"R74-20240215","doi-asserted-by":"crossref","first-page":"26604","DOI":"10.18632\/oncotarget.8445","article-title":"PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"R75-20240215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jgr.2016.03.007","article-title":"Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase\/T-LAK cell-originated protein kinase","volume":"40","author":"Yang","year":"2016","journal-title":"J Ginseng Res"},{"key":"R76-20240215","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/nar\/gkw012","article-title":"New players in heterochromatin silencing: histone variant H3.3 and the ATRX\/DAXX chaperone","volume":"44","author":"Voon","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R77-20240215","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"R78-20240215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"R79-20240215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"R80-20240215","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"key":"R81-20240215","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"key":"R82-20240215","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/jclinpath-2014-202514","article-title":"Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies","volume":"67","author":"Ross","year":"2014","journal-title":"J Clin Pathol"},{"key":"R83-20240215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/ERC-13-0112","article-title":"Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors","volume":"21","author":"De Martino","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R84-20240215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12020-013-9878-1","article-title":"Everolimus therapy for progressive adrenocortical cancer","volume":"44","author":"Fraenkel","year":"2013","journal-title":"Endocrine"},{"key":"R85-20240215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-017-9473-8","article-title":"Tissue expression and pharmacological in vitro analyses of mTOR and SSTR pathways in adrenocortical carcinoma","volume":"28","author":"Germano","year":"2017","journal-title":"Endocr Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201802000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T02:02:22Z","timestamp":1707962542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201802000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000943","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}